Indrayani Biotech Ltd has postponed the schedule of its partly paid-up rights issue until further notice. The Rights Issue Committee took this decision at a meeting held on June 22, 2026. The company had previously finalized the issue schedule and terms in earlier communications on April 09, 2026, and May 25, 2026.

The rights issue was initially scheduled to open on Wednesday, May 27, 2026, and close on Thursday, June 25, 2026. This timeline was subsequently extended to close on Friday, July 24, 2026. However, the entire schedule now stands postponed. The revised opening and closing dates will be communicated separately once finalized by the committee.

Despite the postponement, the company confirmed that the terms relating to the offer price and the rights entitlement ratio will remain the same as previously approved and intimated to the stock exchange.

Key Details of the Postponement

The updated issue documents will be made available on the websites of BSE Limited and Indrayani Biotech Ltd upon finalization of the revised schedule. The meeting regarding this postponement commenced at 3.30 P.M. and concluded at 3.55 P.M. on June 22, 2026.

Indrayani Biotech Limited's Company Secretary and Compliance Officer, Ramya Ravi, resigned from her positions effective June 3, 2026, due to professional reasons. The company confirmed that the resignation, which takes effect at the close of business on the said date, was not driven by any material reasons other than those stated in her resignation letter. Indrayani Biotech stated it will make arrangements for a replacement and notify the exchange accordingly in due course.

Resignation Details

The disclosure was made to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company clarified that the cessation of the officer's role is solely due to professional reasons and no other factors necessitated the departure.

Key Information